First Time Drug Reactions: When Your Body Doesn't Need Practice скачать в хорошем качестве

First Time Drug Reactions: When Your Body Doesn't Need Practice

How can you have a life-threatening reaction to a drug you’ve never taken before? We’re taught that allergies require "prior sensitization"—that your body has to meet a substance once before it can build the IgE antibodies needed for a reaction. But in the world of drug reactions, that rule is broken more times than not. In this video, we dive into the fascinating (and sometimes scary) world of non-IgE mediated allergies. We explore the "backdoors" to your mast cell—like the clunky-named MRGPRX2 receptor—and why your medical records might be labeled with a "pseudo-allergy" that isn’t "pseudo" at all. I also share my own personal story of an IV drug reaction at age 15 that changed the way my immune system functioned. 🔍 What we cover: Reaction to medication first time The mast cell's other receptors Difference between IgE and non-IgE mediated drug allergies EAACI nomenclature and retiring the term "pseudo allergy" Delabeling drug allergies and how it can improve medical care and save money How estrogen affects allergies Trauma connection: can your cells "learn" to be overreactive? ⏱️ Timestamps: 0:00 - The Mystery of First-Time Reactions 1:15 - How IgE Allergy Works 1:32 - MRGPRX2 and Other Receptors 3:57 - "Pseudo-Allergy" is Outdated 4:31 - The Importance of "Delabeling" 6:37 - DIES: a Delayed Severe Drug Reaction 7:22 - My Story: When the IV Turned Searing Hot 7:42 - Estrogen, Puberty, and Allergic Trauma 8:42 - Summary: Non-IgE Mediated Drug Allergies 🔗 Resources Mentioned: Alvarez-Arango, S., Kumar, M., Chow, T. G., & Sabato, V. (2024). Non-IgE-mediated Immediate Drug-Induced Hypersensitivity Reactions. The Journal of Allergy and Clinical Immunology: In Practice. Minaldi, E., & Cahill, K. (2023). Recent updates in understanding NSAID hypersensitivity. Current Allergy and Asthma Reports, 23(3), 181-188. Chow, T. G., Oppenheimer, J., & Joshi, S. R. (2022). A review of adverse reactions to biologics used in allergy-immunology practice. The Journal of Allergy and Clinical Immunology: In Practice, 10(12), 3075-3086. Johansson, S. G. O., Hourihane, J. B., Bousquet, J., Bruijnzeel‐Koomen, C., Dreborg, S., Haahtela, T., ... & Wüthrich, B. (2001). A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy, 56(9), 813-824. Kolkhir, P., Ali, H., Babina, M., Ebo, D., Sabato, V., Elst, J., ... & Maurer, M. (2023). MRGPRX2 in drug allergy: What we know and what we do not know. The Journal of allergy and clinical immunology, 151(2), 410. Lieberman, P., & Garvey, L. H. (2016). Mast cells and anaphylaxis. Current allergy and asthma reports, 16, 1-7. Eyraud, C., Biermé, P., Adam, M., & Braun, C. (2023). Drug-induced enterocolitis syndrome: a rare, severe, non-IgE-mediated immediate drug allergy. Case report and literature review. Archives de Pédiatrie, 30(1), 67-70. Mast cell figure at timestamp 1:43 from Fig. 1. Worm, M., Pazur, K., Morakabati, P., & Redhu, D. (2025). IgE and non-IgE-mediated pathways in anaphylaxis. Seminars in immunopathology, 47(1), 34. used under CC BY 4.0 (https://creativecommons.org/licenses/... Cropped from original #Allergy #Immunology #DrugAllergy #FPIES #MastCell #MedicalMystery #NonIgEMediated IMPORTANT MEDICAL DISCLAIMER This video is for general informational purposes only and is not intended as medical advice. I am not a medical doctor or licensed healthcare professional. What is shared is based on my personal experience and research. It should not be used as a substitute for professional medical diagnosis, treatment, or advice.